ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Their core work

Erasmus MC is one of Europe's largest university medical centers, combining patient care, medical research, and education in Rotterdam. Their H2020 portfolio reveals deep expertise in population health, disease prevention, and translational medicine — turning genomic and epidemiological findings into better screening, diagnostics, and personalized treatments. They are particularly strong in large-scale cohort studies tracking health across the life course, from embryonic development to aging, and in building the data infrastructure (FAIR, bioinformatics) needed to make medical research reusable across Europe.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2017), Erasmus MC focused heavily on disease-specific genomics, next-generation sequencing, and large epidemiological cohorts studying chronic diseases like Alzheimer's, stroke, and thyroid disorders. By the later period (2018–2021), the center shifted markedly toward data infrastructure and methodology — FAIR principles, bioinformatics, machine learning, and research infrastructure became dominant themes, alongside a continued but broadened focus on personalised medicine. This evolution reflects a move from generating clinical data to building the frameworks that make such data findable, interoperable, and actionable across institutions.

Erasmus MC is positioning itself as a hub for FAIR-compliant medical data infrastructure, making it an increasingly valuable partner for any consortium that needs to integrate, share, or reuse health data across borders.

How they like to work

With 53 coordinated projects out of 173, Erasmus MC leads roughly 30% of its consortia — a high coordination rate for a university medical center, indicating strong project management capacity. Their 1,326 unique partners across 70 countries make them one of the most connected medical research organizations in H2020, functioning as a major European hub rather than a niche specialist. This breadth means they bring not just their own expertise but access to a vast network of clinical, data, and technology partners.

Erasmus MC has collaborated with 1,326 unique partners across 70 countries, making it one of the most networked medical institutions in H2020. Their reach extends well beyond Europe into global health partnerships, particularly in infectious disease and epidemiology.

What sets them apart

Erasmus MC combines clinical hospital infrastructure with massive population cohort data (Generation R, Rotterdam Study) and growing FAIR data expertise — a combination few medical centers can match. Their 30% coordination rate shows they don't just contribute expertise but actively design and manage complex multi-country research programs. For consortium builders, they offer a rare triple package: clinical validation capability, population-scale datasets, and the data governance know-how to make results shareable under EU open science requirements.

Highlights from their portfolio

• MYOP-PATH
  Coordinated EUR 2M ERC-style project on myopia genetics-to-pathways — reflects their strength in translating genomic findings into mechanistic understanding.
• COMPARE
  EUR 2.7M participation in a major outbreak detection platform, their largest single-project funding, linking infectious disease surveillance with bioinformatics.
• EU-TOPIA
  Coordinated EUR 1.6M project to improve cancer screening across all of Europe — demonstrates their leadership in population-level health policy translation.